These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 22964948)
1. Infusional β-lactam antibiotics in febrile neutropenia: has the time come? Abbott IJ; Roberts JA Curr Opin Infect Dis; 2012 Dec; 25(6):619-25. PubMed ID: 22964948 [TBL] [Abstract][Full Text] [Related]
2. Continuous infusion of beta-lactam antibiotics in severe infections: a review of its role. Roberts JA; Paratz J; Paratz E; Krueger WA; Lipman J Int J Antimicrob Agents; 2007 Jul; 30(1):11-8. PubMed ID: 17442541 [TBL] [Abstract][Full Text] [Related]
3. Continuous infusion vs. bolus dosing: implications for beta-lactam antibiotics. Mohd Hafiz AA; Staatz CE; Kirkpatrick CM; Lipman J; Roberts JA Minerva Anestesiol; 2012 Jan; 78(1):94-104. PubMed ID: 21730935 [TBL] [Abstract][Full Text] [Related]
4. Continuous-infusion beta-lactam antibiotics during continuous venovenous hemofiltration for the treatment of resistant gram-negative bacteria. Moriyama B; Henning SA; Neuhauser MM; Danner RL; Walsh TJ Ann Pharmacother; 2009 Jul; 43(7):1324-37. PubMed ID: 19584386 [TBL] [Abstract][Full Text] [Related]
5. Subtleties in practical application of prolonged infusion of β-lactam antibiotics. De Waele JJ; Lipman J; Carlier M; Roberts JA Int J Antimicrob Agents; 2015 May; 45(5):461-3. PubMed ID: 25749200 [TBL] [Abstract][Full Text] [Related]
6. [Possibilities and limits of ambulatory supportive measures in oncology exemplified by antibiotic therapy of febrile neutropenia]. Karthaus M; Meran JG; Geissler RG; Böhme A; Jürgens H; Ganser A Wien Med Wochenschr; 1998; 148(18):427-32. PubMed ID: 9888179 [TBL] [Abstract][Full Text] [Related]
7. Optimizing use of beta-lactam antibiotics in the critically ill. Roberts JA; Lipman J Semin Respir Crit Care Med; 2007 Dec; 28(6):579-85. PubMed ID: 18095221 [TBL] [Abstract][Full Text] [Related]
8. Prolonged administration of β-lactam antibiotics - a comprehensive review and critical appraisal. Osthoff M; Siegemund M; Balestra G; Abdul-Aziz MH; Roberts JA Swiss Med Wkly; 2016; 146():w14368. PubMed ID: 27731492 [TBL] [Abstract][Full Text] [Related]
9. β-lactam pharmacokinetics and pharmacodynamics in critically ill patients and strategies for dose optimization: a structured review. Sinnollareddy MG; Roberts MS; Lipman J; Roberts JA Clin Exp Pharmacol Physiol; 2012 Jun; 39(6):489-96. PubMed ID: 22519600 [TBL] [Abstract][Full Text] [Related]
10. Revisiting Beta-lactams - PK/PD improves dosing of old antibiotics. MacGowan A Curr Opin Pharmacol; 2011 Oct; 11(5):470-6. PubMed ID: 21862409 [TBL] [Abstract][Full Text] [Related]
11. Prolonged infusions of β-lactam antibiotics: implication for antimicrobial stewardship. George JM; Towne TG; Rodvold KA Pharmacotherapy; 2012 Aug; 32(8):707-21. PubMed ID: 23307519 [TBL] [Abstract][Full Text] [Related]
12. Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial. Dulhunty JM; Roberts JA; Davis JS; Webb SA; Bellomo R; Gomersall C; Shirwadkar C; Eastwood GM; Myburgh J; Paterson DL; Lipman J Clin Infect Dis; 2013 Jan; 56(2):236-44. PubMed ID: 23074313 [TBL] [Abstract][Full Text] [Related]
13. Improving antibiotic dosing in special situations in the ICU: burns, renal replacement therapy and extracorporeal membrane oxygenation. Jamal JA; Economou CJ; Lipman J; Roberts JA Curr Opin Crit Care; 2012 Oct; 18(5):460-71. PubMed ID: 22820155 [TBL] [Abstract][Full Text] [Related]
14. Continuous and Prolonged Intravenous β-Lactam Dosing: Implications for the Clinical Laboratory. Grupper M; Kuti JL; Nicolau DP Clin Microbiol Rev; 2016 Oct; 29(4):759-72. PubMed ID: 27413094 [TBL] [Abstract][Full Text] [Related]
15. Continuing education: alternative approaches to optimizing antimicrobial pharmacodynamics in critically ill patients. Winterboer TM; Lecci KA; Olsen KM J Pharm Pract; 2010 Feb; 23(1):6-18. PubMed ID: 21507788 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of extended infusion of β-lactam antibiotics for the treatment of febrile neutropenia in haematologic patients: protocol for a randomised, multicentre, open-label, superiority clinical trial (BEATLE). Laporte-Amargos J; Gudiol C; Arnan M; Puerta-Alcalde P; Carmona-Torre F; Huguet M; Albasanz-Puig A; Parody R; Garcia-Vidal C; Del Pozo JL; Batlle M; Tebé C; Rigo-Bonnin R; Muñoz C; Padullés A; Tubau F; Videla S; Sureda A; Carratalà J Trials; 2020 May; 21(1):412. PubMed ID: 32423462 [TBL] [Abstract][Full Text] [Related]
17. Prolonging β-lactam infusion: a review of the rationale and evidence, and guidance for implementation. MacVane SH; Kuti JL; Nicolau DP Int J Antimicrob Agents; 2014 Feb; 43(2):105-13. PubMed ID: 24359838 [TBL] [Abstract][Full Text] [Related]
18. [Application of the concepts of evidence-based medicine to the evidence on the treatment of febrile neutropenia]. Jarque I; Sanz MA Enferm Infecc Microbiol Clin; 1999; 17 Suppl 2():95-102. PubMed ID: 10605194 [TBL] [Abstract][Full Text] [Related]
19. [Antimicrobial therapy of febrile neutropenia--current developments]. Karthaus M; Cornely OA; Südhoff T; Meran J Wien Med Wochenschr; 2001; 151(3-4):66-72. PubMed ID: 11789421 [TBL] [Abstract][Full Text] [Related]
20. Continuous and extended infusions of β-lactam antibiotics in the pediatric population. Walker MC; Lam WM; Manasco KB Ann Pharmacother; 2012 Nov; 46(11):1537-46. PubMed ID: 23115223 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]